Vimarsana
Biggest News Aggregation in the World

Exploratory Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exploratory Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exploratory Efficacy Today - Breaking & Trending Today

Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom... - Vimarsana News

Inozyme Pharma To Present Recently Announced Data From Phase 1/2 Trials Of INZ-701 In Adults With ENPP1 Deficiency And ABCC6 Deficiency (PXE) At Upcom...

BOSTON, May 23, 2024 (GLOBE NEWSWIRE) --

Source: menafn.com
Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings - Vimarsana News

Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings

LA JOLLA, Calif., August 30, 2023--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th International Epilepsy Congress (IEC) and the American College of Clinical Pharmacology (ACCP) Annual Meeting.

Source: yahoo.com
Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings - Vimarsana News

Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings

30.08.2023 - Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will present new and encore data at the 35th ... Seite 1

HistoIndex's Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet's NASH FASCINATE-2 Phase 2b Clinical Trial - Vimarsana News

HistoIndex's Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet's NASH FASCINATE-2 Phase 2b Clinical Trial

/PRNewswire/ -- HistoIndex, a global leading artificial intelligence (AI) digital pathology provider, has announced an agreement with clinical-stage...